Yüklüyor......
Immunotherapy of multiple myeloma
Multiple myeloma (MM), a bone marrow–resident hematological malignancy of plasma cells, has remained largely incurable despite dramatic improvements in patient outcomes in the era of myeloma-targeted and immunomodulatory agents. It has recently become clear that T cells from MM patients are able to...
Kaydedildi:
| Yayımlandı: | J Clin Invest |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108923/ https://ncbi.nlm.nih.gov/pubmed/32149732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI129205 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|